T37.5X2A Poisoning by antiviral drugs, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by antiviral drugs, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting in poisoning from antiviral medications during an initial medical encounter. It includes deliberate exposure to antiviral agents with the intent to cause harm, leading to acute toxicity. The focus is on the acute phase of poisoning at the time of first evaluation.

Causes

Intentional self-harm poisoning may occur from deliberate overdose or misuse of antiviral drugs. Common scenarios include intentional ingestion of excessive doses, manipulation of dosing regimens, or use of antiviral agents in a manner inconsistent with prescribed therapy. Underlying psychiatric or emotional factors may contribute to the behavior.

Risk Factors

• History of suicidal ideation or prior self-harm attempts.
• Concurrent mental health conditions (e.g., depression, anxiety).
• Access to antiviral medications without supervision.
• Social or environmental stressors increasing risk of self-harm.
• Lack of supportive mental health resources or intervention.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, or diarrhea.
• Neurological: Dizziness, confusion, headache, or seizures.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Hepatic: Elevated liver enzymes or jaundice.
• Renal: Acute kidney injury or electrolyte imbalances.
• Cardiovascular: Arrhythmias or hypotension.

Diagnosis

Clinical evaluation based on patient history, medication use, and symptom presentation. Laboratory tests assess drug levels, organ function (e.g., liver, kidney), and toxicology screens. Psychiatric assessment is critical to determine intent and plan intervention. Imaging or other studies are used as clinically indicated.

Treatment Options

Management focuses on stabilizing the patient, removing unabsorbed drug (e.g., activated charcoal), and supportive care (e.g., fluid resuscitation, antiemetics). Specific antidotes are not available for most antiviral drugs. Psychiatric evaluation and intervention are essential to address underlying self-harm intent.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Close monitoring for organ dysfunction and recurrence of self-harm is necessary. Follow-up includes psychiatric care, medication management, and safety planning to reduce future risk.

Complications

• Organ failure (e.g., hepatic, renal) from toxicity.
• Seizures or neurological damage.
• Electrolyte imbalances or metabolic disturbances.
• Psychiatric complications, including persistent suicidal ideation.
• Long-term effects from drug-induced injury.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Regular mental health screening and support.
• Education on safe medication use and disposal.
• Development of crisis intervention plans.
• Engagement with mental health services for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention for suspected poisoning, especially with intentional self-harm. Signs include altered mental status, severe symptoms (e.g., seizures, organ dysfunction), or known exposure to antiviral drugs. Prompt evaluation is critical to prevent complications.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Include details on the antiviral agent involved, clinical findings, and psychiatric assessment. Ensure coding aligns with the specific circumstances of the poisoning and encounter.